US Patent 6906028 Stable insulin formulations
Patent 6906028 was granted and assigned to Eli Lilly and Company on June, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Oct, 2023
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+402 characters)
Article
Patent abstract
The present invention provides a monomeric insulin analog formulation stabilized against aggregation in which the buffering agent is either TRIS or arginine. The stable formulations of the present invention are useful for treating diabetes, and are particularly advantageous in treatment regimes requiring lengthy chemical and physical stability, such as, in continuous infusion systems.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Bruce Hill Frank0
Dawn Marie Rebhun0
Michael Allen Dobbins0
Michael Rosario DeFelippis0
Shun Li0
Date of Patent
June 14, 2005
0Patent Application Number
102641760
Date Filed
October 3, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6906028 Stable insulin formulations
Find more entities like US Patent 6906028 Stable insulin formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
